Toru Nawa - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Toru Nawa

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Gastroenterology and Hepatology|February 7, 2019

Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologicsToshihiro Inokuchi, Sakuma Takahashi, Sakiko Hiraoka, et al.

European Journal of Gastroenterology & Hepatology|August 6, 2008

Clinical factors that impair health-related quality of life in ulcerative colitis patients vary with the disease durationMotoaki Kuriyama, Jun Kato, Kenji Kuwaki, et al.

Cureus|February 3, 2025

Bleeding Risk During Colorectal Endoscopic Mucosal Resection With Continued Anticoagulant Therapy: A Multicenter StudySayo Kobayashi, Keita Harada, Toru Nawa, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Gastroenterology and Hepatology|February 7, 2019

Long-term outcomes of patients with Crohn's disease who received infliximab or adalimumab as the first-line biologicsToshihiro Inokuchi, Sakuma Takahashi, Sakiko Hiraoka, et al.

European Journal of Gastroenterology & Hepatology|August 6, 2008

Clinical factors that impair health-related quality of life in ulcerative colitis patients vary with the disease durationMotoaki Kuriyama, Jun Kato, Kenji Kuwaki, et al.

Cureus|February 3, 2025

Bleeding Risk During Colorectal Endoscopic Mucosal Resection With Continued Anticoagulant Therapy: A Multicenter StudySayo Kobayashi, Keita Harada, Toru Nawa, et al.

Pageof 2